Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery
Objective: The objective of this clinical trial is to study the effectiveness of administering recombinant activated factor VII (rFVIIa) in reducing the amount of bleeding and the need for homologous blood and products transfusion in cardiac surgical coronary revascularization procedures done under...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Saudi Journal of Anaesthesia |
Subjects: | |
Online Access: | http://www.saudija.org/article.asp?issn=1658-354X;year=2013;volume=7;issue=3;spage=301;epage=304;aulast=Abdel-Meguid |